US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist

34.670
-1.760-4.83%

Close Jun 14 16:00 ET

34.670
0.0000.00%

Post 16:49 ET

2.29BMarket Cap-12122P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-42.25%-40.64M

-3.43%-107.29M

-49.49%-32.53M

46.03%-18.99M

-22.26%-27.2M

-16.45%-28.57M

-70.31%-103.73M

-49.85%-21.76M

-114.95%-35.19M

-86.45%-22.24M

Net income from continuing operations

-11.74%-32.81M

-25.91%-141.43M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.5M

-27.38%-29.36M

-59.30%-112.33M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36M

Operating gains losses

--8K

----

108.33%2K

200.00%1K

-5,700.00%-56K

----

Depreciation and amortization

6.75%775K

3.87%3.01M

12.78%759K

14.31%767K

2.02%756K

-10.48%726K

-5.61%2.9M

-13.38%673K

-10.77%671K

-3.01%741K

Deferred tax

----

--0

----

--0

----

Other non cash items

----

-388.40%-6.86M

--0

-2,551.94%-6.33M

Change In working capital

-314.25%-12.5M

445.36%13.46M

7,563.08%4.98M

195.79%13.01M

-109.85%-1.51M

46.90%-3.02M

-269.83%-3.9M

-96.30%65K

-728.56%-13.58M

1,688.58%15.3M

-Change in receivables

95.55%-43K

-1,203.43%-2.28M

-1,403.80%-2.38M

-45.65%-134K

719.18%1.2M

-1,261.97%-967K

-111.12%-175K

-732.00%-158K

-137.86%-92K

-89.04%146K

-Change in prepaid assets

-328.10%-6.21M

161.64%5.9M

352.01%4.14M

226.39%1.82M

-108.15%-2.78M

138.08%2.72M

-411.60%-9.57M

-521.54%-1.64M

177.68%557K

-325.46%-1.34M

-Change in payables and accrued expense

-38.66%-4.78M

200.48%9.38M

61.34%3.88M

163.18%8.48M

-97.17%478K

-25.93%-3.45M

-14.51%3.12M

26.74%2.4M

-635.22%-13.42M

3,170.54%16.88M

-Change in other current assets

----

---3K

--0

----

--0

----

-Change in other current liabilities

-10.87%-1.47M

-83.05%462K

-23.69%-663K

555.93%2.85M

-2.07%-395K

-131.01%-1.33M

161.88%2.73M

2.55%-536K

-591.34%-624K

88.63%-387K

Cash from discontinued investing activities

Operating cash flow

-42.25%-40.64M

-3.43%-107.29M

-49.49%-32.53M

46.03%-18.99M

-22.26%-27.2M

-16.45%-28.57M

-70.31%-103.73M

-49.85%-21.76M

-114.95%-35.19M

-86.45%-22.24M

Investing cash flow

Cash flow from continuing investing activities

-699.61%-315.21M

-217.61%-105.78M

-648.36%-171.16M

-49.51%11.65M

-95.40%1.16M

406.45%52.57M

141.61%89.94M

264.76%31.21M

110.17%23.07M

281.72%25.28M

Net PPE purchase and sale

41.20%-344K

0.55%-1.82M

-183.40%-666K

54.49%-157K

39.08%-410K

-1.74%-585K

-46.36%-1.83M

33.62%-235K

-86.49%-345K

-370.63%-673K

Net investment purchase and sale

-692.37%-314.87M

-213.37%-103.96M

-642.15%-170.5M

-49.44%11.8M

-93.94%1.57M

385.20%53.15M

142.66%91.7M

269.15%31.45M

110.30%23.34M

288.50%25.95M

Net other investing changes

----

155.56%69K

--0

----

Cash from discontinued investing activities

Investing cash flow

-699.61%-315.21M

-217.61%-105.78M

-648.36%-171.16M

-49.51%11.65M

-95.40%1.16M

406.45%52.57M

141.61%89.94M

264.76%31.21M

110.17%23.07M

281.72%25.28M

Financing cash flow

Cash flow from continuing financing activities

62,740.35%436.11M

5,259.62%218.46M

15,482.37%217.37M

-88.86%257K

87.32%133K

128.29%694K

-98.50%4.08M

227.46%1.4M

-99.15%2.31M

384.00%71K

Net common stock issuance

--432.3M

--216.22M

----

--0

----

Proceeds from stock option exercised by employees

449.57%3.81M

-45.14%2.24M

-17.42%1.15M

-88.86%257K

87.32%133K

128.29%694K

64.42%4.08M

227.46%1.4M

15.07%2.31M

384.00%71K

Cash from discontinued financing activities

Financing cash flow

62,740.35%436.11M

5,259.62%218.46M

15,482.37%217.37M

-88.86%257K

87.32%133K

128.29%694K

-98.50%4.08M

227.46%1.4M

-99.15%2.31M

384.00%71K

Net cash flow

Beginning cash position

18.30%34.81M

-24.82%29.43M

13.73%21.13M

-0.62%28.22M

113.98%54.12M

-24.82%29.43M

-10.71%39.14M

-74.26%18.58M

-34.63%28.4M

-63.51%25.29M

Current changes in cash

225.03%80.26M

155.44%5.39M

26.13%13.68M

27.79%-7.09M

-933.30%-25.9M

278.30%24.69M

-106.99%-9.71M

132.83%10.85M

-134.16%-9.82M

112.02%3.11M

End cash Position

112.62%115.08M

18.30%34.81M

13.73%21.13M

-0.62%28.22M

113.98%54.12M

-24.82%29.43M

-74.26%18.58M

-34.63%28.4M

Free cash flow

-40.57%-40.98M

-3.36%-109.11M

-50.93%-33.2M

46.11%-19.15M

-20.46%-27.61M

-16.11%-29.15M

-69.83%-105.56M

-47.86%-22M

-114.63%-35.54M

-89.82%-22.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-42.25%-40.64M	-3.43%-107.29M	-49.49%-32.53M	46.03%-18.99M	-22.26%-27.2M	-16.45%-28.57M	-70.31%-103.73M	-49.85%-21.76M	-114.95%-35.19M	-86.45%-22.24M
Net income from continuing operations	-11.74%-32.81M	-25.91%-141.43M	-63.50%-43.31M	-42.85%-38.26M	15.28%-30.5M	-27.38%-29.36M	-59.30%-112.33M	-31.46%-26.49M	-30.96%-26.78M	-169.23%-36M
Operating gains losses	--8K	----	----	----	----	----	108.33%2K	200.00%1K	-5,700.00%-56K	----
Depreciation and amortization	6.75%775K	3.87%3.01M	12.78%759K	14.31%767K	2.02%756K	-10.48%726K	-5.61%2.9M	-13.38%673K	-10.77%671K	-3.01%741K
Deferred tax	----	--0	----	----	----	----	--0	----	----	----
Other non cash items	----	----	----	----	----	----	-388.40%-6.86M	--0	--0	-2,551.94%-6.33M
Change In working capital	-314.25%-12.5M	445.36%13.46M	7,563.08%4.98M	195.79%13.01M	-109.85%-1.51M	46.90%-3.02M	-269.83%-3.9M	-96.30%65K	-728.56%-13.58M	1,688.58%15.3M
-Change in receivables	95.55%-43K	-1,203.43%-2.28M	-1,403.80%-2.38M	-45.65%-134K	719.18%1.2M	-1,261.97%-967K	-111.12%-175K	-732.00%-158K	-137.86%-92K	-89.04%146K
-Change in prepaid assets	-328.10%-6.21M	161.64%5.9M	352.01%4.14M	226.39%1.82M	-108.15%-2.78M	138.08%2.72M	-411.60%-9.57M	-521.54%-1.64M	177.68%557K	-325.46%-1.34M
-Change in payables and accrued expense	-38.66%-4.78M	200.48%9.38M	61.34%3.88M	163.18%8.48M	-97.17%478K	-25.93%-3.45M	-14.51%3.12M	26.74%2.4M	-635.22%-13.42M	3,170.54%16.88M
-Change in other current assets	----	---3K	--0	--0	----	----	--0	--0	--0	----
-Change in other current liabilities	-10.87%-1.47M	-83.05%462K	-23.69%-663K	555.93%2.85M	-2.07%-395K	-131.01%-1.33M	161.88%2.73M	2.55%-536K	-591.34%-624K	88.63%-387K
Cash from discontinued investing activities
Operating cash flow	-42.25%-40.64M	-3.43%-107.29M	-49.49%-32.53M	46.03%-18.99M	-22.26%-27.2M	-16.45%-28.57M	-70.31%-103.73M	-49.85%-21.76M	-114.95%-35.19M	-86.45%-22.24M
Investing cash flow
Cash flow from continuing investing activities	-699.61%-315.21M	-217.61%-105.78M	-648.36%-171.16M	-49.51%11.65M	-95.40%1.16M	406.45%52.57M	141.61%89.94M	264.76%31.21M	110.17%23.07M	281.72%25.28M
Net PPE purchase and sale	41.20%-344K	0.55%-1.82M	-183.40%-666K	54.49%-157K	39.08%-410K	-1.74%-585K	-46.36%-1.83M	33.62%-235K	-86.49%-345K	-370.63%-673K
Net investment purchase and sale	-692.37%-314.87M	-213.37%-103.96M	-642.15%-170.5M	-49.44%11.8M	-93.94%1.57M	385.20%53.15M	142.66%91.7M	269.15%31.45M	110.30%23.34M	288.50%25.95M
Net other investing changes	----	----	----	----	----	----	155.56%69K	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-699.61%-315.21M	-217.61%-105.78M	-648.36%-171.16M	-49.51%11.65M	-95.40%1.16M	406.45%52.57M	141.61%89.94M	264.76%31.21M	110.17%23.07M	281.72%25.28M
Financing cash flow
Cash flow from continuing financing activities	62,740.35%436.11M	5,259.62%218.46M	15,482.37%217.37M	-88.86%257K	87.32%133K	128.29%694K	-98.50%4.08M	227.46%1.4M	-99.15%2.31M	384.00%71K
Net common stock issuance	--432.3M	--216.22M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	449.57%3.81M	-45.14%2.24M	-17.42%1.15M	-88.86%257K	87.32%133K	128.29%694K	64.42%4.08M	227.46%1.4M	15.07%2.31M	384.00%71K
Cash from discontinued financing activities
Financing cash flow	62,740.35%436.11M	5,259.62%218.46M	15,482.37%217.37M	-88.86%257K	87.32%133K	128.29%694K	-98.50%4.08M	227.46%1.4M	-99.15%2.31M	384.00%71K
Net cash flow
Beginning cash position	18.30%34.81M	-24.82%29.43M	13.73%21.13M	-0.62%28.22M	113.98%54.12M	-24.82%29.43M	-10.71%39.14M	-74.26%18.58M	-34.63%28.4M	-63.51%25.29M
Current changes in cash	225.03%80.26M	155.44%5.39M	26.13%13.68M	27.79%-7.09M	-933.30%-25.9M	278.30%24.69M	-106.99%-9.71M	132.83%10.85M	-134.16%-9.82M	112.02%3.11M
End cash Position	112.62%115.08M	18.30%34.81M	18.30%34.81M	13.73%21.13M	-0.62%28.22M	113.98%54.12M	-24.82%29.43M	-24.82%29.43M	-74.26%18.58M	-34.63%28.4M
Free cash flow	-40.57%-40.98M	-3.36%-109.11M	-50.93%-33.2M	46.11%-19.15M	-20.46%-27.61M	-16.11%-29.15M	-69.83%-105.56M	-47.86%-22M	-114.63%-35.54M	-89.82%-22.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall